News
Feed
Events
Feed
News
+ Events
Feed

goetzpartners securities Limited

  • Country United Kingdom

Latest News

9 July 2019

13:50 Corporate

goetzpartners securities Limited

Corporate

Vivoryon Therapeutics (PBD-NA): Agreement with MOR in I-O, earlier than expected

25 June 2019

16:15 Corporate

goetzpartners securities Limited

Corporate

Abivax SA (ABVX-FR): Ready to deal with inflammation

21 June 2019

08:53 Corporate

goetzpartners securities Limited

Corporate

Mauna Kea Technologies SA (MKEA-FR): Reimbursement decision facilitates Cellvizio penetration in France

15 June 2019

14:34 Corporate

goetzpartners securities Limited

Corporate

Vivoryon Therapeutics (PBD-NA): Fresh funding for AD. Immuno-oncology optionality explored

29 May 2019

19:03 Corporate

goetzpartners securities Limited

Corporate

Marinomed Biotech AG: Q1 masks solid sales performance in most markets

22 May 2019

16:53 Corporate

goetzpartners securities Limited

Corporate

Evotec SE (EVT-DE): Evotec expands into high-growth biologics segment

17 May 2019

08:23 Corporate

goetzpartners securities Limited

Corporate

Vicore Pharma Holding AB (VICO-SE): Key activities on track at Q1/2019 update

16 May 2019

15:23 Corporate

goetzpartners securities Limited

Corporate

Advanced Oncotherapy (AVO-GB): Strong fundamentals underpin future growth

15:16 Corporate

goetzpartners securities Limited

Corporate

Epigenomics (ECX-DE): Key catalysts to fuel growth throughout 2019

15:08 Corporate

goetzpartners securities Limited

Corporate

Evotec SE (EVT-DE): Macro trend drives strong start to the year

15:03 Corporate

goetzpartners securities Limited

Corporate

Marinomed Biotech AG (MARI-AT): Budesolv hits key endpoints in Phase III allergy trial

14 May 2019

13:52 Corporate

goetzpartners securities Limited

Corporate

Evotec SE (EVT-DE): Q1 results beat on strong top-line growth

13 May 2019

08:28 Corporate

goetzpartners securities Limited

Corporate

Evotec SE (EVT-DE): Q1/2019E results preview

7 May 2019

08:48 Corporate

goetzpartners securities Limited

Corporate

Marinomed Biotech AG (MARI-AT): 2019E off to a good start. All eyes on Budesolv.

6 May 2019

09:13 Corporate

goetzpartners securities Limited

Corporate

Curetis (CURE-NL): Partnering drives turn-round

26 April 2019

09:56 Corporate

goetzpartners securities Limited

Corporate

Mauna Kea Technologies SA (MKEA-FR): Progressing toward long-term strategic growth

25 April 2019

11:41 Corporate

goetzpartners securities Limited

Corporate

Vicore Pharma Holding AB (VICO-SE): Scleroderma the second indication for VP01 (C21)

11:35 Corporate

goetzpartners securities Limited

Corporate

Marinomed Biotech AG (MARI-AT): Budesolv succeeds in pivotal Phase III trial

23 April 2019

12:32 Corporate

goetzpartners securities Limited

Corporate

Immutep Limited (IMM-AU): Unlocking the value of LAG-3 in autoimmunity

12:26 Corporate

goetzpartners securities Limited

Corporate

Basilea Pharmaceutica AG (BSLN-CH): Derazantinib has potential in iCCA and beyond

16 April 2019

10:11 Corporate

goetzpartners securities Limited

Corporate

Advanced Oncotherapy (AVO-GB): Key talent acquisition reaffirms the promise of LIGHT

9 April 2019

08:55 Corporate

goetzpartners securities Limited

Corporate

Mauna Kea Technologies SA (MKEA-FR): FY2018 results validate move to consignment sales

8 April 2019

09:36 Corporate

goetzpartners securities Limited

Corporate

Evotec SE (EVT-DE): Raising TP to EUR28 on positive momentum

28 March 2019

20:54 Corporate

goetzpartners securities Limited

Corporate

Epigenomics (ECX-DE): 2018 results highlight strong underlying growth momentum

26 March 2019

11:44 Corporate

goetzpartners securities Limited

Corporate

Vicore Pharma Holding AB (VICO-SE): Pipeline on track at FY2018. Moving to IFRS

21 March 2019

09:15 Corporate

goetzpartners securities Limited

Corporate

Marinomed Biotech AG (MARI-AT): Solving the insoluble

20 March 2019

13:33 Corporate

goetzpartners securities Limited

Corporate

Probiodrug (PBD-NA): $15m cash injection from NIH for US Phase IIb in early Alzheimer’s

18 March 2019

21:05 Corporate

goetzpartners securities Limited

Corporate

Telix Pharmaceuticals Limited (TLX-AU): Updated PCa imaging guidelines de-risk lead asset

12 March 2019

09:16 Corporate

goetzpartners securities Limited

Corporate

Nexstim OYJ (NXTMH-FI): FY2018 results reflect growing focus on therapy

11 March 2019

15:54 Corporate

goetzpartners securities Limited

Corporate

Abivax SA (ABVX-FR): ABX464: sustained safety and benefit in inflammatory bowel

Upcoming Events

No Events found